---
authors:
- ReactomeTeam
description: Antimicrobial peptides (AMPs) are small molecular weight proteins with
  broad spectrum of antimicrobial activity against bacteria, viruses, and fungi (Zasloff
  M 2002; Radek K & Gallo R 2007). The majority of known AMPs are cationic peptides
  with common structural characteristics where domains of hydrophobic and cationic
  amino acids are spatially arranged into an amphipathic design, which facilitates
  their interaction with bacterial membranes (Shai Y 2002; Yeaman MR & Yount NY 2003;
  Brown KL & Hancock RE 2006; Dennison SR et al. 2005; Zelezetsky I & Tossi A 2006).
  It is generally excepted that the electrostatic interaction facilitates the initial
  binding of the positively charged peptides to the negatively charged bacterial membrane.
  Moreover, the structural amphiphilicity of AMPs is thought to promote their integration
  into lipid bilayers of pathogenic cells, leading to membrane disintegration and
  finally to the microbial cell death. In addition to cationic AMPs a few anionic
  antimicrobial peptides have been found in humans, however their mechanism of action
  remains to be clarified (Lai Y et al. 2007; Harris F et al. 2009; Paulmann M et
  al. 2012). Besides the direct neutralizing effects on bacteria AMPs may modulate
  cells of the adaptive immunity (neutrophils, T-cells, macrophages) to control inflammation
  and/or to increase bacterial clearance.<p>AMPs have also been referred to as cationic
  host defense peptides, anionic antimicrobial peptides/proteins, cationic amphipathic
  peptides, cationic AMPs, host defense peptides and alpha-helical antimicrobial peptides
  (Brown KL & Hancock RE 2006; Harris F et al. 2009; Groenink J et al. 1999; Bradshaw
  J 2003; Riedl S et al. 2011; Huang Y et al. 2010).<p>The Reactome module describes
  the interaction events of various types of human AMPs, such as cathelicidin, histatins
  and neutrophil serine proteases, with conserved patterns of microbial membranes
  at the host-pathogen interface. The module includes also proteolytic processing
  events for dermcidin (DCD) and cathelicidin (CAMP) that become functional upon cleavage.
  In addition, the module highlights an AMP-associated ability of the host to control
  metal quota at inflammation sites to influence host-pathogen interactions.    View
  original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=6803157 Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4101
- /instance/WP4101
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4101.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Antimicrobial peptides (AMPs) are small molecular weight proteins with
    broad spectrum of antimicrobial activity against bacteria, viruses, and fungi
    (Zasloff M 2002; Radek K & Gallo R 2007). The majority of known AMPs are cationic
    peptides with common structural characteristics where domains of hydrophobic and
    cationic amino acids are spatially arranged into an amphipathic design, which
    facilitates their interaction with bacterial membranes (Shai Y 2002; Yeaman MR
    & Yount NY 2003; Brown KL & Hancock RE 2006; Dennison SR et al. 2005; Zelezetsky
    I & Tossi A 2006). It is generally excepted that the electrostatic interaction
    facilitates the initial binding of the positively charged peptides to the negatively
    charged bacterial membrane. Moreover, the structural amphiphilicity of AMPs is
    thought to promote their integration into lipid bilayers of pathogenic cells,
    leading to membrane disintegration and finally to the microbial cell death. In
    addition to cationic AMPs a few anionic antimicrobial peptides have been found
    in humans, however their mechanism of action remains to be clarified (Lai Y et
    al. 2007; Harris F et al. 2009; Paulmann M et al. 2012). Besides the direct neutralizing
    effects on bacteria AMPs may modulate cells of the adaptive immunity (neutrophils,
    T-cells, macrophages) to control inflammation and/or to increase bacterial clearance.<p>AMPs
    have also been referred to as cationic host defense peptides, anionic antimicrobial
    peptides/proteins, cationic amphipathic peptides, cationic AMPs, host defense
    peptides and alpha-helical antimicrobial peptides (Brown KL & Hancock RE 2006;
    Harris F et al. 2009; Groenink J et al. 1999; Bradshaw J 2003; Riedl S et al.
    2011; Huang Y et al. 2010).<p>The Reactome module describes the interaction events
    of various types of human AMPs, such as cathelicidin, histatins and neutrophil
    serine proteases, with conserved patterns of microbial membranes at the host-pathogen
    interface. The module includes also proteolytic processing events for dermcidin
    (DCD) and cathelicidin (CAMP) that become functional upon cleavage. In addition,
    the module highlights an AMP-associated ability of the host to control metal quota
    at inflammation sites to influence host-pathogen interactions.    View original
    pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=6803157 Reactome].
  keywords:
  - unknown peptidase
  - 'KDO '
  - 'ELANE '
  - Divalent metals
  - ELANE,CTSG,
  - hexamer:Zn(2+):anionic phospholipids
  - RNASEs
  - 'HTN3(20-43) '
  - 'LPS '
  - S100A7, S100A7A:Ca2+
  - 'heptose '
  - ATOX1
  - Defensins
  - H+
  - 'LTF '
  - DCD(63-110):anionic
  - 'DCD(63-110) '
  - 'S100A8 '
  - PLA2G2A:Ca2+
  - cell surface
  - ITLN1 trimer:Ca2+
  - Fe3+
  - HTN1,3,5
  - 'RNASE3 '
  - 'BPIFA2 '
  - 'PGLYRP1 '
  - REG3A(38-175)
  - S100A7,
  - Anionic
  - 'BPIFB6 '
  - LTF
  - PLA2G2A:phospholipids
  - S100A8:S100A9:Ca2+
  - 'REG3A(27-175) '
  - BPIFA/BPIFB:bacterial cell
  - 'CTSG '
  - INTL1:bacterial
  - anionic lipids
  - 'beta-D-galactofuranosyl '
  - REG3A(27-175)/REG3G(27-175)
  - REG3G(38-175)
  - 'PRTN3 '
  - 'SSA2 '
  - CO3(2-)
  - Trypsin 2, 3
  - 'CAMP(134-170) '
  - DCD peptides
  - GNLY:bacterial
  - 'Fe2+ '
  - HTN5,(HTN1, HTN3)
  - 'HTN1(31-57) '
  - 'REG3G(27-175) '
  - REG3A
  - 'MurNAc '
  - INTL1 ligands
  - 'Ca2+ '
  - DCD(63-109)
  - CAMP(31-170)
  - CHGA fragments
  - RNASE3,RNASE7,RNASE6,(RNASE8)
  - 'PDZD11 '
  - HTN5, (HTN1,
  - 'Peptide '
  - H2O
  - 'CLU(23-227) '
  - DCD(20-62)
  - PGLYRP1dimer:peptidoglycan
  - 'REG3A(27-37) '
  - 'BPIFB2 '
  - 'S100A9 '
  - 'hC-EPPIN '
  - 'Anionic phospholipids '
  - EPC:bacterial
  - 'BPI '
  - 'peptidoglycan-NHAc  '
  - 'CHGA(19-94) '
  - 'LYZ '
  - 'Zn2+ '
  - Na+
  - 'CHGA(370-390) '
  - ATP7A:PDZD11
  - LEAP2:bacterial
  - 'RNASE8 '
  - LCN2:2,5DHBA:Fe3+
  - 'RNASE6 '
  - REG3A(38-175),
  - CAMP(134-170)
  - 'hC239-SEMG1 '
  - (GlcNAc+MurNac)n
  - 'S100A7A '
  - HTN1,3,5:bacterial
  - peptide:bacterial
  - phospholipids
  - 'CLU(228-449) '
  - 'Mn2+ '
  - 'BPIFB4 '
  - 'PRSS2(24-247) '
  - S100A8:S100A9:Ca2+:Mn2+:Na+
  - 'PI3(23-117) '
  - phospholipid
  - 'Na+ '
  - MurNAc:Peptide
  - LPS, PGN
  - ATOX1:Cu1+
  - 'REG3G(27-37) '
  - GNLY
  - surface
  - REG3A(27-37)/REG3G(27-37)
  - 'S100A7 '
  - DCD:anionic
  - 'PGLYRP3 '
  - PRTN3
  - PI3
  - 'REG3G(38-175) '
  - transported by
  - DCD
  - LPS
  - DCD(63-110)
  - PGLYRP1 dimer
  - 'LEAP2 '
  - phospholipids:microbial cell surface
  - 'HTN3 '
  - HTN3):SSA1,SSA2
  - L-Ala-gamma-D-Glu-L-Lys-D-Ala
  - 'BPIFA1 '
  - PGLYRP2 dimer
  - GlcNac-(1-->4)MurNAc-L-Ala-gamma-D-Glu-L-Lys-(D-Ala)2
  - '2.5DHBA '
  - Mn2+
  - PRTN3:microbial
  - DCD(20-110)
  - PI3:LPS
  - 'BPIFB1 '
  - EPPIN:SEMG1:LTF:CLU
  - betaGlcNAc
  - LYZ
  - NRAMP1
  - LYZ:PGN
  - 'DCD(63-109) '
  - 'GNLY '
  - S100A7A:Ca2+:Zn2+
  - Microbial cell
  - PGLYRP3,4
  - hexamer:anionic
  - Pi
  - 'GlcNAc(1-->4)MurNAc:L-Ala-gamma-D-Glu-L-Lys-(D-Ala)2 '
  - LTF:2xFe3+:2xCO3(2-)
  - 3,6,7,(8):LPS,PGN
  - 'ITLN1 '
  - PGLYRP2:peptidoglycan
  - BPIFA/BPIFB
  - SLC11A1
  - 'REG3A(38-175) '
  - BPI
  - LCN2:2,5DHBA
  - ELANE, CTSG, PRTN3
  - CAMP(134-170):microbial cell surface
  - 'Cu1+ '
  - 'ATP7A '
  - 'Microbial cell surface '
  - Zn2+
  - ADP
  - 'SSA1 '
  - 'CO3(2-) '
  - ATP
  - 'PRSS3 '
  - 'GlcNac-(1-->4)MurNAc-L-Ala-gamma-D-Glu-L-Lys-(D-Ala)2 '
  - REG3A(38-175):anionic phospholipids
  - LEAP2
  - CHGA-derived
  - 'PGLYRP2 '
  - REG3G(38-175):peptidoglycan
  - 'PLA2G2A '
  - glycan
  - 'LCN2 '
  - dimer:peptidoglycan
  - S100A8:S100A9:Ca2+:Zn2+
  - SSA1,SSA2
  - Cu1+
  - PGLYRP3,4 dimers
  - 'RNASE7 '
  - 'ATOX1 '
  - BPI:LPS
  - 'PGLYRP4 '
  - 3,6,7,(8):anionic
  - 'PI3(61-117) '
  - 'HTN1 '
  - 'Fe3+ '
  license: CC0
  name: Antimicrobial peptides
seo: CreativeWork
title: Antimicrobial peptides
wpid: WP4101
---